Dear Doctor Letter (Rote-Hand-Brief) on Caelyx® (pegylated liposomal doxorubicin): Shortage, introduction of a web-based ordering and reservation system
2012.10.30
Active substance: pegylated liposomal doxorubicin
Supply problems with regard to Caelyx® have been reported in the past. A further letter with information on the reintroduction of Caelyx® is being circulated now. Due to the persisting shortage the company has introduced a web-based ordering and reservation system which is intended to help manage appropriate allocation of available stock to patients in the EU.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN